Way too early for that. Right now focus on customer and revenue growth and refining the product. The earnings will definitely come if revenue continues to grow at this rate.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game